Your browser doesn't support javascript.
loading
Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration-resistant prostate cancer.
Fenioux, Charlotte; Louvet, Christophe; Charton, Emilie; Rozet, Francois; Ropert, Stanislas; Prapotnich, Dominique; Barret, Eric; Sanchez-Salas, Rafael; Mombet, Annick; Cathala, Nathalie; Joulia, Marie-Liesse; Molitor, Jean-Luc; Henriques, Julie; Bonnetain, Franck; Cathelineau, Xavier; Bennamoun, Mostefa.
Afiliação
  • Fenioux C; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Louvet C; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Charton E; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
  • Rozet F; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Ropert S; Department of Medical Oncology, Antony's Private Hospital, Antony, France.
  • Prapotnich D; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Barret E; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Sanchez-Salas R; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Mombet A; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Cathala N; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Joulia ML; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Molitor JL; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Henriques J; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
  • Bonnetain F; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
  • Cathelineau X; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Bennamoun M; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
BJU Int ; 123(2): 300-306, 2019 02.
Article em En | MEDLINE | ID: mdl-30099821
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França